Omega Healthcare Investors (BSP:O2HI34) EBITDA Margin %: 90.98% (As of Mar. 2026) — Near Median


BSP:O2HI34 Omega Healthcare Investors Inc BSP:O2HI34
49 GF Score
Price R$77.02
GF Value R$62.11
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Omega Healthcare Investors EBITDA Margin %?

Omega Healthcare Investors BSP:O2HI34 -0.03% 49 EBITDA Margin % is 90.98% as of Mar. 2026, which is 0% above its 10-year median of 90.94. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$62.11 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 750 REITs companies, Omega Healthcare Investors ranks better than 79.87% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Omega Healthcare Investors's EBITDA for the three months ended in Mar. 2026 was R$1,537 Mil. Omega Healthcare Investors's Revenue for the three months ended in Mar. 2026 was R$1,689 Mil. Therefore, Omega Healthcare Investors's EBITDA margin for the quarter that ended in Mar. 2026 was 90.98%.


Omega Healthcare Investors  (BSP:O2HI34) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Omega Healthcare Investors EBITDA Margin % Related Terms


Omega Healthcare Investors EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Omega Healthcare Investors's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors EBITDA Margin % Chart

Omega Healthcare Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 93.40 114.07 85.38 90.08 97.87

Omega Healthcare Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.15 99.33 106.41 95.79 90.98

BSP:O2HI34 vs DOC, AHR, CTRE: EBITDA Margin % Comparison

For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omega Healthcare Investors EBITDA Margin % vs REITs Industry

For the REITs industry and Real Estate sector, Omega Healthcare Investors's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Omega Healthcare Investors's EBITDA Margin % falls into.


BSP:O2HI34
49GF Score
Omega Healthcare Investors Inc BSP:O2HI34
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omega Healthcare Investors EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Omega Healthcare Investors's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=6354.336/6492.823
=97.87 %

Omega Healthcare Investors's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=1536.524/1688.925
=90.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 90.98% mean?
Omega Healthcare Investors (BSP:O2HI34) has a EBITDA Margin % of 90.98% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Omega Healthcare Investors and its competitors. This is near median its historical median of 90.94. Over the past decade, Omega Healthcare Investors' EBITDA Margin % has ranged from 67.57 to 114.07. According to the industry distribution chart, Omega Healthcare Investors ranks #151 out of 750 companies in the REITs industry, placing it in the top 20.1%.
Is Omega Healthcare Investors' EBITDA Margin % too high?
Omega Healthcare Investors' current EBITDA Margin % of 90.98% is near median its 10-year median of 90.94. Over the past 10 years, this metric has ranged from a low of 67.57 to a high of 114.07. The REITs industry median EBITDA Margin % is 69.61. Omega Healthcare Investors' value of 90.98% is 30.7% above this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #151 out of 750 companies in the REITs industry, which is in the top quartile — a strong position relative to peers. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' EBITDA Margin % compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #151 out of 750 companies for EBITDA Margin %. This places Omega Healthcare Investors in the top 20% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 69.61. Omega Healthcare Investors' value of 90.98% is 30.7% above this benchmark. Historically, Omega Healthcare Investors' own EBITDA Margin % has ranged from 67.57 to 114.07 over the past decade. While the company's 10-year median is 90.94 vs. the industry median of 69.61, Omega Healthcare Investors has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a REITs company?
The median EBITDA Margin % among REITs companies is 69.61, based on 750 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current EBITDA Margin % of 90.98% is 30.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Omega Healthcare Investors and its competitors. For the REITs industry, the median EBITDA Margin % is 69.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current EBITDA Margin % is 90.98%, which is near median its own 10-year median of 90.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$62.11, compared to a current price of R$77.02 — trading 24% above its estimated fair value. The current EBITDA Margin % is 90.98%, which is near median its 10-year median of 90.94 and 30.7% above the REITs industry median of 69.61. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current EBITDA Margin % is 90.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of R$77.02 is trading 24% above its estimated GF Value™ of R$62.11. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for BSP:O2HI34:

  • EBITDA Margin %: 90.98% (near median its 10-year median of 90.94)
  • GF Value™: R$62.11 vs. price of R$77.02 (24% above fair value)
  • GF Score™: 49/100 with 6 warning signs
  • Industry Position: 30.7% above the REITs median (#151 of 750)

No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score

Get the complete analysis for BSP:O2HI34

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$77.02
Price
R$62.11
GF Value